Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
Crossref DOI link: https://doi.org/10.1007/s40262-017-0530-8
Published Online: 2017-03-13
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lindauer, Andreas
Laveille, Christian
Stockis, Armel
Funding for this research was provided by:
UCB Pharma (Brussels, Belgium)
License valid from 2017-03-13